Surgical Specialties Corporation Launches Caliber Ophthalmics Division to Focus on Global Growth of Ophthalmic Surgical Procedures

Food and Healthcare Press Releases Tuesday May 21, 2019 13:30
WESTWOOD, Massachusetts--21 May--PRNewswire/InfoQuest

Surgical Specialties Corporation (SSC) announced today the launch of Caliber Ophthalmics, a new business division. Caliber Ophthalmics combines SSC's Sharpoint(TM) brand, which has earned a trusted reputation serving ophthalmic surgeons for over 50 years, with its two recent ophthalmic acquisitions, Unique Technologies, Inc. and VPM Surgical, Inc.

To lead the Caliber Ophthalmics Division, SSC has named Yong Sun, General Manager Ophthalmology and Vice President, International Sales.   Mr. Sun has over 20 years of experience in the medical device and life science industries. He has held leadership roles in general management and commercial operations with Harvard Bioscience, Beaver-Visitec International (BVI), BD Medical Ophthalmics and Booz & Company. Mr. Sun holds an MBA from MIT's Sloan School of Management.

Best known in the ophthalmic market for Sharpoint microsurgical knives and surgical sutures, SSC has specialized in the design and manufacture of high-performance surgical knives and wound closure products since 1969. The Company's products are sold globally in more than ninety countries.   With the addition of Unique Technologies and VPM Surgical, the Company significantly expands its development and manufacturing expertise in ophthalmic blades and cutting instrumentation, and plans to add an ophthalmology manufacturing and engineering center of excellence in Pennsylvania.

"We are at an important inflection point in the ophthalmic industry with an expanding global economy and an increasing aging population," said Dan Croteau, CEO of Surgical Specialties. "There has been remarkable technology advancement in eye care and tremendous growth in eye surgeries. We created the Caliber Ophthalmics Division to focus on the growing needs of   ophthalmic customers around the world."

Mr. Croteau continued, "Caliber Ophthalmics brings together a unique and strong legacy of delivering quality, performance and innovation at competitive costs. With Yong Sun leading this new division, we are well positioned to not only deliver continued innovation and quality in our existing product lines, but have additional expertise that will allow us to expand into other ophthalmic product categories."

About Surgical Specialties

Surgical Specialties Corporation, headquartered in Westwood, MA, has developed and manufactured branded, private label, and OEM surgical instruments for over 50 years. Surgical Specialties Corporation offers one of the most comprehensive portfolios of blades and sutures available, including innovative products such as the Quill(TM) Knotless Tissue-Closure Device.   SSC is dedicated to exceeding the needs of the specialty surgery market, maintaining trusted partnerships in the dental, ophthalmic, plastic surgery, dermatology, orthopedics, urology, microsurgery, veterinary and trauma specialties.   Visit us at www.surgicalspecialties.com and www.caliberophthalmics.com .

Media contact:
Matt Bastardi
SVP Commercial & Strategy
Surgical Specialties Corporation
mbastardi@surgicalspecialties.com
Logo - https://mma.prnewswire.com/media/326014/Surgical_Specialties_Corporation_Logo.jpg

Latest Press Release

Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established cardiovascular disease or high cardiovascular risk in PIONEER 6 trial

Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The...

Zeus Expands Portfolio with New Polyimide Family of Products

Products Include PI Tubing, PI Coated Wire, PI Glide(TM) Tubing, and PI Glide(TM) Coated Wire Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, has announced the introduction of a new polyimide...

SCG partners up with Frances Institut Pasteur to combat dengue with innovations to reduce mosquito breeding

Dr. Suracha Udomsak, Chief Technology Officer, on behalf of Chemicals Business, SCG, and Dr. Anavaj Sakuntabhai, Coordinator of the Defeat Dengue Program, Head of Structure, Functional Genetics of Infectious Diseases, representing Institut Pasteur,...

เอสซีจี จับมือ สถาบันปาสเตอร์ ฝรั่งเศส หยุดการระบาดของโรคไข้เลือดออกด้วยการพัฒนานวัตกรรมลดการแพร่พันธุ์ยุงลาย

ธุรกิจเคมิคอลส์ เอสซีจี โดย ดร.สุรชา อุดมศักดิ์ Chief Technology Officer และ สถาบันปาสเตอร์ ประเทศฝรั่งเศส (Institut Pasteur) โดย ดร. อนวัช ศกุนตาภัย Coordinator of the Defeat Dengue Program, Head of Structure, Functional Genetics of Infectious Diseases,...

Oral semaglutide showed superior reductions in blood sugar vs Jardiance(R) and non-inferior blood sugar reductions vs Victoza(R) in adults with type 2 diabetes at 26 weeks

Secondary data at 52 weeks demonstrated statistically significant blood sugar reductions and statistically significant reduction of body weight vs both Jardiance(R) and Victoza(R) Findings presented today from two phase 3a clinical trials evaluated oral...

Related Topics